Tue, Sep 16, 2014, 9:06 AM EDT - U.S. Markets open in 24 mins.

Recent

% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • terry_amln terry_amln Jun 10, 2014 7:26 AM Flag

    European update on ASCO studies ( this am)

     

    Multiple studies presented at 2014 ASCO annual meeting reinforce unique, practice-changing value of Oncotype DX® breast cancer test
    Demonstrate importance of consistent results from multiple validation studies
    Highlight substantial differences between multi-gene tests
    Reinforce Genomic Healthâ#$%$™s commitment to improving the quality of treatment decisions for cancer patients
    GENEVA, Switzerland--(BUSINESS WIRE)-- Genomic Health, Inc. (Nasdaq: GHDX) announced results of three studies with the Oncotype DX breast cancer test at the recent 2014 American Society of Clinical Oncology® (ASCO®) Annual Meeting.

    This topic is deleted.
 
GHDX
28.28Sep 15 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.